| RS1553282545 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D |
| RS1553282635 |
HNRNPU
|
Health Risk |
Pathogenic |
— |
| RS1553282698 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553282707 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553282723 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS1553282754 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS1553282768 |
TNNT2
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D |
| RS1553283037 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553283111 |
LYST
|
Health Risk |
Likely pathogenic |
— |
| RS1553283444 |
HNRNPU
|
Health Risk |
Pathogenic |
— |
| RS1553283831 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1553283895 |
HNRNPU
|
Health Risk |
Pathogenic |
heterogeneous nuclear ribonucleoprotein G, human |
| RS1553283899 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS1553283916 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS1553283946 |
HNRNPU
|
Health Risk |
Pathogenic |
— |
| RS1553283951 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS1553283982 |
HNRNPU
|
Health Risk |
Pathogenic |
— |
| RS1553284007 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS1553284965 |
RPL5
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553284997 |
RPL5
|
Health Risk |
Pathogenic/Likely pathogenic |
17 conditions, Diamond-Blackfan anemia |
| RS1553285919 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553285944 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553285970 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553286278 |
CACNA1E
|
Health Risk |
Likely pathogenic |
— |
| RS1553286282 |
CACNA1E
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 69 |
| RS1553286808 |
NLRP3
|
Health Risk |
Pathogenic |
Cryopyrin associated periodic syndrome, Cryopyrin associated periodic syndrome |
| RS1553287070 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553287116 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553287118 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553287287 |
NLRP3
|
Health Risk |
Likely pathogenic |
— |
| RS1553288180 |
CAMTA1
|
Health Risk |
Likely pathogenic |
— |
| RS1553288266 |
CAMTA1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553288362 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Hereditary cancer-predisposing syndrome |
| RS1553288555 |
CENPF
|
Health Risk |
Likely pathogenic |
— |
| RS1553289042 |
TBX19
|
Health Risk |
Pathogenic |
Congenital isolated adrenocorticotropic hormone deficiency, Congenital isolated adrenocorticotropic hormone deficiency |
| RS1553289863 |
HAX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kostmann syndrome, Kostmann syndrome |
| RS1553290222 |
CENPF
|
Health Risk |
Likely pathogenic |
— |
| RS1553292099 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS1553292105 |
TGFB2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553292112 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS1553292123 |
TGFB2
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1553292145 |
TGFB2
|
Health Risk |
Likely pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS1553292987 |
FBXO28
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, See cases |
| RS1553293095 |
NLRP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hearing loss, autosomal dominant 34 |
| RS1553294134 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553294144 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553295440 |
MYT1L
|
Health Risk |
Pathogenic |
— |
| RS1553295536 |
MSTO1
|
Health Risk |
Pathogenic |
Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome, Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome |
| RS1553297209 |
MYT1L
|
Health Risk |
Pathogenic |
— |
| RS1553297684 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553298240 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome, Usher syndrome type 2A |
| RS1553299022 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1553299046 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553299079 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553300016 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553300340 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553300558 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553300632 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia |
| RS1553303161 |
TGFB2
|
Health Risk |
Likely pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS1553303203 |
TGFB2
|
Health Risk |
Pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS1553303213 |
TGFB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Loeys-Dietz syndrome 4, Familial thoracic aortic aneurysm and aortic dissection |
| RS1553303221 |
TGFB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Loeys-Dietz syndrome 4, Loeys-Dietz syndrome 4 |
| RS1553303352 |
TGFB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Loeys-Dietz syndrome 4, TGFB2-related disorder |
| RS1553303357 |
TGFB2
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Loeys-Dietz syndrome 4 |
| RS1553303745 |
TGFB2
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1553303871 |
ACTN2
|
Health Risk |
Likely pathogenic |
— |
| RS1553305080 |
KIDINS220
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, intellectual disability |
| RS1553308328 |
MYT1L
|
Health Risk |
Likely pathogenic |
— |
| RS1553308501 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS1553309983 |
TRAPPC12
|
Health Risk |
Likely pathogenic |
Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome, Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome |
| RS1553310744 |
PPP1CB
|
Health Risk |
Likely pathogenic |
— |
| RS1553311527 |
PPP1CB
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome-like disorder with loose anagen hair 2, Noonan syndrome-like disorder with loose anagen hair 2 |
| RS1553311645 |
HADHA
|
Health Risk |
Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS1553311647 |
HADHA
|
Health Risk |
Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS1553311706 |
HADHA
|
Health Risk |
Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS1553311716 |
HADHA
|
Health Risk |
Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS1553311804 |
HADHA
|
Health Risk |
Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS1553312033 |
HADHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS1553312058 |
HADHA
|
Health Risk |
Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS1553312368 |
NPHS2
|
Health Risk |
Likely pathogenic |
— |
| RS1553312493 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2, Usher syndrome type 2 |
| RS1553312586 |
HADHA
|
Health Risk |
Pathogenic |
— |
| RS1553312833 |
NPHS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS1553313308 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553313340 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553313505 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553313551 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553313793 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1553313810 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553313844 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553313859 |
WDR35
|
Health Risk |
Pathogenic |
Cranioectodermal dysplasia 2, Cranioectodermal dysplasia 2 |
| RS1553313909 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1553314023 |
HADHA
|
Health Risk |
Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS1553314024 |
HADHA
|
Health Risk |
Pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS1553314070 |
HADHA
|
Health Risk |
Likely pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Squamous cell carcinoma of the head and neck |
| RS1553314868 |
SPAST
|
Health Risk |
Pathogenic |
— |
| RS1553314880 |
SPAST
|
Health Risk |
Pathogenic |
— |
| RS1553314896 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1553314902 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia, Hereditary spastic paraplegia 4 |
| RS1553314948 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |